Tag: Codexis

The biotechnology firm Codexis is transitioning its operations from a research-focused phase to establishing industrial production capabilities. Central to this ...

Biotechnology firm Codexis finds itself navigating a critical transition. Recent quarterly results paint a picture of significant revenue contraction, even ...

The story of Codexis presents investors with a classic high-risk, high-reward scenario. The enzyme technology specialist is navigating a critical ...